These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 9352392)

  • 1. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
    Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
    Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncology.
    Yates JWT; Mistry HB
    CPT Pharmacometrics Syst Pharmacol; 2023 Nov; 12(11):1591-1601. PubMed ID: 37771203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern Recognition in Pharmacodynamic Data Analysis.
    Gabrielsson J; Hjorth S
    AAPS J; 2016 Jan; 18(1):64-91. PubMed ID: 26542613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic Effects of an Angiotensin II Receptor-Antagonist in Phase I-Comparison between Healthy Subjects and Patients with Hypertension.
    Wensing G; Ochmann K; Boettcher M; Schäfer A; Kuhlmann J
    Biomark Insights; 2007 Mar; 2():81-93. PubMed ID: 19662194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of lacidipine.
    Hall ST; Harding SM; Evans GL; Pellegatti M; Rizzini P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S9-13. PubMed ID: 1726014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
    Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man.
    Malerczyk C; Fuchs B; Belz GG; Roll S; Butzer R; Breithaupt-Grögler K; Herrmann V; Magin SG; Högemann A; Voith B; Mutschler E
    Br J Clin Pharmacol; 1998 Jun; 45(6):567-73. PubMed ID: 9663812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
    Lyons D; Webster J; Nixon A; Young MM; Smith J; Benjamin N
    Br J Clin Pharmacol; 1997 Mar; 43(3):323-6. PubMed ID: 9088589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.
    Belz GG
    Br J Clin Pharmacol; 2003 Jul; 56(1):3-10. PubMed ID: 12848769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.